Clin2
NCT06252220Likely a fitRecruiting

Testing a new drug for obesity in healthy adults

Obesity

Part of Hormones & metabolism clinical trials.

This trial tests a new medication called DA-1726 for people with obesity but no other major health problems. It aims to see if the drug is safe and how it works in the body. You may qualify if your body mass index (BMI) is between 30 and 45 and your weight has been stable for 3 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
139 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have obesity with a BMI between 30 and 45.
  • Your weight has not changed by more than 5% in the last 3 months.
  • You are willing to keep your current diet and exercise routine during the study.
  • You do not have diabetes, heart problems, or a history of pancreatitis.
  • You are not currently taking any weight-loss medications or participating in a weight-loss program.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07731139Not yet recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07754474Not yet recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07662122Recruiting· Phase 2
Testing a new weight loss medication in adults with obesity or overweight

This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.

Birmingham, Alabama

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.